Back
Gilead Sciences Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Buy
76
GILD
Gilead Sciences
Last Price:
$110.05
Seasonality Move:
5.28%
Sell
40
REGN
Regeneron Pharmaceuticals
Last Price:
$696.47
Seasonality Move:
1.02%
Buy
76
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
-
The current Gilead Sciences [GILD] share price is $107.65. The Score for GILD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
GILD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals [REGN] share price is $685.66. The Score for REGN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $107.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GILD is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $685.66The current trend is relatively stagnant and REGN is experiencing slight buying pressure.
GILD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.25 | Buy |
Relative Strength Index (14 RSI): | 73.33 | Buy |
Chaikin Money Flow: | 5322861 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.61 | Sell |
Relative Strength Index (14 RSI): | 47.3 | Sell |
Chaikin Money Flow: | 350934 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
GILD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 101.74 | Buy |
20-day SMA: | 98.3 | Buy |
50-day SMA: | 94.49 | Buy |
200-day SMA: | 81.63 | Buy |
8-day EMA: | 103.06 | Buy |
20-day EMA: | 99.33 | Buy |
50-day EMA: | 95.42 | Buy |
200-day EMA: | 85.84 | Buy |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 680.4 | Buy |
20-day SMA: | 685.54 | Buy |
50-day SMA: | 708.32 | Sell |
200-day SMA: | 935.26 | Sell |
8-day EMA: | 681.63 | Buy |
20-day EMA: | 687.86 | Sell |
50-day EMA: | 720.48 | Sell |
200-day EMA: | 858.79 | Sell |
Gilead Sciences Earnings Growth & GILD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, a decrease next quarter of $0.15 per share, an increase this year of $3.52 per share, and an increase next year of $0.34 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.85 per share, an increase next quarter of $0.43 per share, a decrease this year of $1.83 per share, and an increase next year of $3.98 per share.
Gilead Sciences Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |